TR201905619T4 - Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri. - Google Patents

Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri. Download PDF

Info

Publication number
TR201905619T4
TR201905619T4 TR2019/05619T TR201905619T TR201905619T4 TR 201905619 T4 TR201905619 T4 TR 201905619T4 TR 2019/05619 T TR2019/05619 T TR 2019/05619T TR 201905619 T TR201905619 T TR 201905619T TR 201905619 T4 TR201905619 T4 TR 201905619T4
Authority
TR
Turkey
Prior art keywords
fusion proteins
peptide carrier
allergy vaccines
carrier fusion
allergy
Prior art date
Application number
TR2019/05619T
Other languages
English (en)
Inventor
Niespodziana Katarzyna
Focke-Tejkl Margarete
Vrtala Susanne
Banerjee Srinita
Chen Kuan-Wei
Weber Milena
Valenta Rudolf
Marth Katharina
Original Assignee
Biomay Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomay Ag filed Critical Biomay Ag
Publication of TR201905619T4 publication Critical patent/TR201905619T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

Buluş, alerjilerin tedavisinde yararlı olan, viral protein alerjen protein fragmanlarının füzyonuna ilişkindir.
TR2019/05619T 2011-06-09 2012-06-11 Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri. TR201905619T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11169365 2011-06-09

Publications (1)

Publication Number Publication Date
TR201905619T4 true TR201905619T4 (tr) 2019-05-21

Family

ID=46354215

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/05619T TR201905619T4 (tr) 2011-06-09 2012-06-11 Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.

Country Status (17)

Country Link
US (2) US9308251B2 (tr)
EP (1) EP2717910B1 (tr)
JP (1) JP6170912B2 (tr)
CN (1) CN103687617B (tr)
AU (1) AU2012266246B2 (tr)
BR (1) BR112013031505B1 (tr)
CA (1) CA2838217C (tr)
DK (1) DK2717910T3 (tr)
ES (1) ES2720140T3 (tr)
HU (1) HUE042761T2 (tr)
MX (1) MX343386B (tr)
PL (1) PL2717910T3 (tr)
PT (1) PT2717910T (tr)
RU (1) RU2630652C2 (tr)
TR (1) TR201905619T4 (tr)
WO (1) WO2012168487A1 (tr)
ZA (1) ZA201309399B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT503530A1 (de) * 2006-04-28 2007-11-15 Biomay Ag Polypeptid mit allergenen eigenschaften
US9308251B2 (en) * 2011-06-09 2016-04-12 Biomay Ag Peptide carrier fusion proteins as allergy vaccines
WO2013001362A2 (en) * 2011-06-27 2013-01-03 Anergis S.A. Contiguous overlapping peptides for treatment of ragweed pollen allergy
CA2933552A1 (en) 2013-12-23 2015-07-02 Alk-Abello A/S Peptide combinations and uses thereof in treating dust mite allergy
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
WO2015185767A1 (es) * 2014-06-04 2015-12-10 Abbcn, S.L. Etiquetas peptídicas para el marcaje de proteínas por fusión, y anticuerpos para su detección
WO2017004561A1 (en) 2015-07-01 2017-01-05 Alk-Abelló A/S Peptide combinations and uses thereof for treating grass allergy
EP3138579A1 (en) * 2015-09-05 2017-03-08 Biomay Ag Fusion protein for use in the treatment of a hepatitis b virus infection
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
EP3295956A1 (en) 2016-09-20 2018-03-21 Biomay Ag Polypeptide construct comprising fragments of allergens
CN110325202B (zh) 2016-10-31 2023-10-31 佐治亚州立大学研究基金会公司 乙型肝炎病毒pre-S蛋白的病毒样颗粒
EP3569612A1 (en) 2018-05-18 2019-11-20 Biomay Ag Treatment and prevention of house dust mite allergies
RU2761431C9 (ru) * 2020-10-26 2022-04-18 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии
EP4134674A1 (en) 2021-08-13 2023-02-15 Euroimmun Medizinische Labordiagnostika AG Methods and reagents for detecting an antibody to a ses ipr-10 allergen
WO2023046898A1 (en) 2021-09-23 2023-03-30 Viravaxx AG Hbv vaccine inducing pres-specific neutralizing antibodies
WO2023242436A1 (en) 2022-06-17 2023-12-21 Danmarks Tekniske Universitet Allergy vaccines based on consensus allergens
CN116726198B (zh) * 2023-03-13 2024-02-13 陕西师范大学 一种抗肿瘤药物及其在脑胶质瘤治疗中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
RU2285042C2 (ru) * 2000-11-16 2006-10-10 Альк-Абелло А/С Новые мутантные аллергены
AU2003251604A1 (en) 2002-06-26 2004-01-19 F. C. Thomas Allnutt Viruses and virus-like particles for multiple antigen and target display
DK1523329T3 (da) 2002-07-05 2013-10-14 Folia Biotech Inc Viruspartikeladjuvant
AT503530A1 (de) 2006-04-28 2007-11-15 Biomay Ag Polypeptid mit allergenen eigenschaften
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
WO2009130588A2 (en) * 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
EP2295076A1 (en) * 2009-09-10 2011-03-16 Biomay Ag Hypoallergenic hybrid polypeptides for the treatment of allergy
US9308251B2 (en) * 2011-06-09 2016-04-12 Biomay Ag Peptide carrier fusion proteins as allergy vaccines

Also Published As

Publication number Publication date
CN103687617B (zh) 2017-09-15
PT2717910T (pt) 2019-05-22
CA2838217A1 (en) 2012-12-13
WO2012168487A1 (en) 2012-12-13
AU2012266246A1 (en) 2014-01-09
JP6170912B2 (ja) 2017-07-26
PL2717910T3 (pl) 2019-07-31
BR112013031505A2 (pt) 2018-06-26
JP2014518635A (ja) 2014-08-07
MX2013014439A (es) 2014-07-24
CA2838217C (en) 2022-11-01
EP2717910B1 (en) 2019-01-23
BR112013031505B1 (pt) 2023-01-10
ZA201309399B (en) 2016-03-30
MX343386B (es) 2016-11-03
US20140193450A1 (en) 2014-07-10
US9308251B2 (en) 2016-04-12
CN103687617A (zh) 2014-03-26
EP2717910A1 (en) 2014-04-16
US20150335735A1 (en) 2015-11-26
RU2630652C2 (ru) 2017-09-11
HUE042761T2 (hu) 2019-07-29
US9844591B2 (en) 2017-12-19
AU2012266246B2 (en) 2017-05-11
ES2720140T3 (es) 2019-07-18
RU2013157115A (ru) 2015-07-20
DK2717910T3 (en) 2019-04-15

Similar Documents

Publication Publication Date Title
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
MX2019007921A (es) Nuevos agentes de union a ha.
UY34254A (es) Proteínas y péptidos modificados.
BR112015022208A8 (pt) proteínas de fusão que compreendem pdgf e partes de ligação de vegf, e métodos de utilização do mesmo
PH12015500284A1 (en) Interleukin-10 fusion proteins and uses thereof
EA201391175A1 (ru) Гетеродимерные иммуноглобулины
EA201500172A1 (ru) Модифицированные полипептиды фактора х и их применение
EP2928924A4 (en) HIV-1 ENV BINDING ANTIBODIES, FUSION PROTEINS AND METHODS OF USE
EA201171494A1 (ru) Миметики белка smac
EP2709603A4 (en) MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS AND APPLICATIONS THEREWITH
DK3578659T3 (da) Kunstige nukelinsyremolekyler til forbedret protein- eller peptidekspression
EA201290590A1 (ru) Модифицированные туберкулезные антигены
EP2651964A4 (en) NETWORKED PEPTIDES AND PROTEINS, METHOD FOR THEIR PREPARATION AND USES THEREOF
EA201491784A1 (ru) Антитела против лигандов рецептора в1 брадикинина
DK3434775T3 (da) Protein med nukleaseaktivitet, fusionsproteiner og anvendelser deraf
EA201291065A1 (ru) Антитела против vla-4
HK1198244A1 (en) New proteases able to hydrolyze gluten peptides and proteins at acidic ph, from the actinomycete actinoallomurus (actinoallomurus) ph
MX366178B (es) Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos.
DK2782598T3 (da) Rekombinante proteiner og terapeutiske anvendelser deraf
MD20150109A2 (ro) Construcţii proteice mitocondriale şi utilizările acestora
MA37749B1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
EA201792608A3 (ru) Применение белков p3 бактериофага в качестве агентов, связывающих амилоид
BR112015004629A2 (pt) polipeptídeos de clostridium difficile como vacinas
EA201390955A1 (ru) Слитый белок robo1-fc для применения в лечении гепатокарциномы
EP2928492A4 (en) Hiv-1 envelope proteins and fragments thereof that possess epitopes recognized by broadly neutralizing antibodies